Our experience in this sector covers traditional M&A, product-related transactions, research and development, new product launch, in-license and out-license, private equity and venture capital investment, domestic and overseas capital markets, regulatory and compliance advices, data protection and vertical and horizontal monopoly arrangements.
Our clients range from large and medium-sized pharmaceutical companies, innovative pharmaceutical firms, medical device companies, professional sales organizations, CROs, hospitals and industry associations to private equity funds and venture capital businesses. We advise companies headquartered in the U.S., Europe, China and across Asia.
We are set up in such a way to offer clients a seamless service across offices and practice areas. We provide integrated teams drawn from different legal disciplines to cover every angle of a deal. We recognize the importance of identifying early the key legal issues and planning a strategy to ensure the most effective management of any transaction on which we are retained. One team, one solution is our practiced method of working.